The high activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
Among the most popular fund investment industries, there are Blockchain, Software. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Ultrain
The typical case for the fund is to invest in rounds with 10 participants. Despite the Norther Capital, startups are often financed by Morningside Venture Capital, Hongtai Capital Holdings, Draper Dragon. The meaningful sponsors for the fund in investment in the same round are Spark Digital Capital, Sky9 Capital, Sailor Capital.
| Fund Name | Location |
| Fresenius Medical Care North America | Massachusetts, United States, Waltham |
| KGI Venture Capital | - |
| NextStage | Amsterdam, Noord-Holland, The Netherlands |
| Orient Assets Management | Beijing, Beijing, China |
| SKS Ventures | China, Shanghai |
| The Wellcome Trust Centre for Human Genetics | - |
| Weifang Huazheng Yonghui Equity Investment | China, Shandong, Weifang |
| Xinchanghong Power Technology | China, Jiangsu, Jiangyin |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ultrain | $20M | 30 Jul 2018 | Shangcheng District, Zhejiang, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ultrain | $20M | 30 Jul 2018 | Shangcheng District, Zhejiang, China |
